Stage III Breast Cancer Active Not Recruiting Phase 2 Trials for Pertuzumab (DB06366)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02326974T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCATreatment